Selected research
Market Analysis & Forecast
Global Membrane Technology in Pharmaceutical Market Analysis and Forecast 2026-2032
Market perspective
Global Membrane Technology in Pharmaceutical key players include Cytiva, Merck Millipore, Pall Corporation, etc. Global top 3 manufacturers hold a share over 38%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 49 percent.
In terms of product, Microfiltration is the largest segment, with a share over 39%. And in terms of application, the largest application is Pharmaceutical.
Read the full market overview
Report Includes
This report presents an overview of global market for Membrane Technology in Pharmaceutical, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Membrane Technology in Pharmaceutical, also provides the revenue of main regions and countries. Of the upcoming market potential for Membrane Technology in Pharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Membrane Technology in Pharmaceutical revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Membrane Technology in Pharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Membrane Technology in Pharmaceutical revenue, projected growth trends, production technology, application and end-user industry.
Membrane Technology in Pharmaceutical Segment by Company
Cytiva
Merck Millipore
Pall Corporation
3M
Sartorius Group
Thermo Fisher Scientific
DuPont
Parker Hannifin
Koch Separation Solutions
Amazon Filters
Advantec
Microdyn-Nadir
Membrane Solutions
Membrane Technology in Pharmaceutical Segment by Type
Microfiltration
Ultrafiltration
Nanofiltration
Reverse Osmosis
Others
Membrane Technology in Pharmaceutical Segment by Application
Pharmaceutical
Biopharmaceutical
Life Science
Membrane Technology in Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Membrane Technology in Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Membrane Technology in Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Membrane Technology in Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Membrane Technology in Pharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Membrane Technology in Pharmaceutical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Membrane Technology in Pharmaceutical revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microfiltration
- Ultrafiltration
- Nanofiltration
- Reverse Osmosis
- Others
Applications
- Pharmaceutical
- Biopharmaceutical
- Life Science
Companies covered
- Cytiva
- Merck Millipore
- Pall Corporation
- 3M
- Sartorius Group
- Thermo Fisher Scientific
- DuPont
- Parker Hannifin
- Koch Separation Solutions
- Amazon Filters
- Advantec
- Microdyn-Nadir
- Membrane Solutions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Membrane Technology in Pharmaceutical Market by Type
- 1.2.1 Global Membrane Technology in Pharmaceutical Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Microfiltration
- 1.2.3 Ultrafiltration
- 1.2.4 Nanofiltration
- 1.2.5 Reverse Osmosis
- 1.2.6 Others
- 1.3 Membrane Technology in Pharmaceutical Market by Application
- 1.3.1 Global Membrane Technology in Pharmaceutical Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical
- 1.3.3 Biopharmaceutical
- 1.3.4 Life Science
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Membrane Technology in Pharmaceutical Market Dynamics
- 2.1 Membrane Technology in Pharmaceutical Industry Trends
- 2.2 Membrane Technology in Pharmaceutical Industry Drivers
- 2.3 Membrane Technology in Pharmaceutical Industry Opportunities and Challenges
- 2.4 Membrane Technology in Pharmaceutical Industry Restraints
3 Global Growth Perspective
- 3.1 Global Membrane Technology in Pharmaceutical Market Perspective (2021-2032)
- 3.2 Global Membrane Technology in Pharmaceutical Growth Trends by Region
- 3.2.1 Global Membrane Technology in Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Membrane Technology in Pharmaceutical Market Size by Region (2021-2026)
- 3.2.3 Global Membrane Technology in Pharmaceutical Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Membrane Technology in Pharmaceutical Revenue by Players
- 4.1.1 Global Membrane Technology in Pharmaceutical Revenue by Players (2021-2026)
- 4.1.2 Global Membrane Technology in Pharmaceutical Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Membrane Technology in Pharmaceutical Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Membrane Technology in Pharmaceutical Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Membrane Technology in Pharmaceutical Key Players Headquarters & Area Served
- 4.4 Global Membrane Technology in Pharmaceutical Players, Product Type & Application
- 4.5 Global Membrane Technology in Pharmaceutical Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Membrane Technology in Pharmaceutical Market CR5 and HHI
- 4.6.3 2025 Membrane Technology in Pharmaceutical Tier 1, Tier 2, and Tier 3
5 Membrane Technology in Pharmaceutical Market Size by Type
- 5.1 Global Membrane Technology in Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Membrane Technology in Pharmaceutical Revenue by Type (2021-2032)
- 5.3 Global Membrane Technology in Pharmaceutical Revenue Market Share by Type (2021-2032)
6 Membrane Technology in Pharmaceutical Market Size by Application
- 6.1 Global Membrane Technology in Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Membrane Technology in Pharmaceutical Revenue by Application (2021-2032)
- 6.3 Global Membrane Technology in Pharmaceutical Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Cytiva
- 7.1.1 Cytiva Company Information
- 7.1.2 Cytiva Business Overview
- 7.1.3 Cytiva Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.1.4 Cytiva Membrane Technology in Pharmaceutical Product Portfolio
- 7.1.5 Cytiva Recent Developments
- 7.2 Merck Millipore
- 7.2.1 Merck Millipore Company Information
- 7.2.2 Merck Millipore Business Overview
- 7.2.3 Merck Millipore Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.2.4 Merck Millipore Membrane Technology in Pharmaceutical Product Portfolio
- 7.2.5 Merck Millipore Recent Developments
- 7.3 Pall Corporation
- 7.3.1 Pall Corporation Company Information
- 7.3.2 Pall Corporation Business Overview
- 7.3.3 Pall Corporation Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.3.4 Pall Corporation Membrane Technology in Pharmaceutical Product Portfolio
- 7.3.5 Pall Corporation Recent Developments
- 7.4 3M
- 7.4.1 3M Company Information
- 7.4.2 3M Business Overview
- 7.4.3 3M Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.4.4 3M Membrane Technology in Pharmaceutical Product Portfolio
- 7.4.5 3M Recent Developments
- 7.5 Sartorius Group
- 7.5.1 Sartorius Group Company Information
- 7.5.2 Sartorius Group Business Overview
- 7.5.3 Sartorius Group Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.5.4 Sartorius Group Membrane Technology in Pharmaceutical Product Portfolio
- 7.5.5 Sartorius Group Recent Developments
- 7.6 Thermo Fisher Scientific
- 7.6.1 Thermo Fisher Scientific Company Information
- 7.6.2 Thermo Fisher Scientific Business Overview
- 7.6.3 Thermo Fisher Scientific Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.6.4 Thermo Fisher Scientific Membrane Technology in Pharmaceutical Product Portfolio
- 7.6.5 Thermo Fisher Scientific Recent Developments
- 7.7 DuPont
- 7.7.1 DuPont Company Information
- 7.7.2 DuPont Business Overview
- 7.7.3 DuPont Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.7.4 DuPont Membrane Technology in Pharmaceutical Product Portfolio
- 7.7.5 DuPont Recent Developments
- 7.8 Parker Hannifin
- 7.8.1 Parker Hannifin Company Information
- 7.8.2 Parker Hannifin Business Overview
- 7.8.3 Parker Hannifin Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.8.4 Parker Hannifin Membrane Technology in Pharmaceutical Product Portfolio
- 7.8.5 Parker Hannifin Recent Developments
- 7.9 Koch Separation Solutions
- 7.9.1 Koch Separation Solutions Company Information
- 7.9.2 Koch Separation Solutions Business Overview
- 7.9.3 Koch Separation Solutions Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.9.4 Koch Separation Solutions Membrane Technology in Pharmaceutical Product Portfolio
- 7.9.5 Koch Separation Solutions Recent Developments
- 7.10 Amazon Filters
- 7.10.1 Amazon Filters Company Information
- 7.10.2 Amazon Filters Business Overview
- 7.10.3 Amazon Filters Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.10.4 Amazon Filters Membrane Technology in Pharmaceutical Product Portfolio
- 7.10.5 Amazon Filters Recent Developments
- 7.11 Advantec
- 7.11.1 Advantec Company Information
- 7.11.2 Advantec Business Overview
- 7.11.3 Advantec Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.11.4 Advantec Membrane Technology in Pharmaceutical Product Portfolio
- 7.11.5 Advantec Recent Developments
- 7.12 Microdyn-Nadir
- 7.12.1 Microdyn-Nadir Company Information
- 7.12.2 Microdyn-Nadir Business Overview
- 7.12.3 Microdyn-Nadir Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.12.4 Microdyn-Nadir Membrane Technology in Pharmaceutical Product Portfolio
- 7.12.5 Microdyn-Nadir Recent Developments
- 7.13 Membrane Solutions
- 7.13.1 Membrane Solutions Company Information
- 7.13.2 Membrane Solutions Business Overview
- 7.13.3 Membrane Solutions Membrane Technology in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 7.13.4 Membrane Solutions Membrane Technology in Pharmaceutical Product Portfolio
- 7.13.5 Membrane Solutions Recent Developments
8 North America
- 8.1 North America Membrane Technology in Pharmaceutical Revenue (2021-2032)
- 8.2 North America Membrane Technology in Pharmaceutical Revenue by Type (2021-2032)
- 8.2.1 North America Membrane Technology in Pharmaceutical Revenue by Type (2021-2026)
- 8.2.2 North America Membrane Technology in Pharmaceutical Revenue by Type (2027-2032)
- 8.3 North America Membrane Technology in Pharmaceutical Revenue Share by Type (2021-2032)
- 8.4 North America Membrane Technology in Pharmaceutical Revenue by Application (2021-2032)
- 8.4.1 North America Membrane Technology in Pharmaceutical Revenue by Application (2021-2026)
- 8.4.2 North America Membrane Technology in Pharmaceutical Revenue by Application (2027-2032)
- 8.5 North America Membrane Technology in Pharmaceutical Revenue Share by Application (2021-2032)
- 8.6 North America Membrane Technology in Pharmaceutical Revenue by Country
- 8.6.1 North America Membrane Technology in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Membrane Technology in Pharmaceutical Revenue by Country (2021-2026)
- 8.6.3 North America Membrane Technology in Pharmaceutical Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Membrane Technology in Pharmaceutical Revenue (2021-2032)
- 9.2 Europe Membrane Technology in Pharmaceutical Revenue by Type (2021-2032)
- 9.2.1 Europe Membrane Technology in Pharmaceutical Revenue by Type (2021-2026)
- 9.2.2 Europe Membrane Technology in Pharmaceutical Revenue by Type (2027-2032)
- 9.3 Europe Membrane Technology in Pharmaceutical Revenue Share by Type (2021-2032)
- 9.4 Europe Membrane Technology in Pharmaceutical Revenue by Application (2021-2032)
- 9.4.1 Europe Membrane Technology in Pharmaceutical Revenue by Application (2021-2026)
- 9.4.2 Europe Membrane Technology in Pharmaceutical Revenue by Application (2027-2032)
- 9.5 Europe Membrane Technology in Pharmaceutical Revenue Share by Application (2021-2032)
- 9.6 Europe Membrane Technology in Pharmaceutical Revenue by Country
- 9.6.1 Europe Membrane Technology in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Membrane Technology in Pharmaceutical Revenue by Country (2021-2026)
- 9.6.3 Europe Membrane Technology in Pharmaceutical Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Membrane Technology in Pharmaceutical Revenue (2021-2032)
- 10.2 China Membrane Technology in Pharmaceutical Revenue by Type (2021-2032)
- 10.2.1 China Membrane Technology in Pharmaceutical Revenue by Type (2021-2026)
- 10.2.2 China Membrane Technology in Pharmaceutical Revenue by Type (2027-2032)
- 10.3 China Membrane Technology in Pharmaceutical Revenue Share by Type (2021-2032)
- 10.4 China Membrane Technology in Pharmaceutical Revenue by Application (2021-2032)
- 10.4.1 China Membrane Technology in Pharmaceutical Revenue by Application (2021-2026)
- 10.4.2 China Membrane Technology in Pharmaceutical Revenue by Application (2027-2032)
- 10.5 China Membrane Technology in Pharmaceutical Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Membrane Technology in Pharmaceutical Revenue (2021-2032)
- 11.2 Asia Membrane Technology in Pharmaceutical Revenue by Type (2021-2032)
- 11.2.1 Asia Membrane Technology in Pharmaceutical Revenue by Type (2021-2026)
- 11.2.2 Asia Membrane Technology in Pharmaceutical Revenue by Type (2027-2032)
- 11.3 Asia Membrane Technology in Pharmaceutical Revenue Share by Type (2021-2032)
- 11.4 Asia Membrane Technology in Pharmaceutical Revenue by Application (2021-2032)
- 11.4.1 Asia Membrane Technology in Pharmaceutical Revenue by Application (2021-2026)
- 11.4.2 Asia Membrane Technology in Pharmaceutical Revenue by Application (2027-2032)
- 11.5 Asia Membrane Technology in Pharmaceutical Revenue Share by Application (2021-2032)
- 11.6 Asia Membrane Technology in Pharmaceutical Revenue by Country
- 11.6.1 Asia Membrane Technology in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Membrane Technology in Pharmaceutical Revenue by Country (2021-2026)
- 11.6.3 Asia Membrane Technology in Pharmaceutical Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Membrane Technology in Pharmaceutical Revenue (2021-2032)
- 12.2 SAMEA Membrane Technology in Pharmaceutical Revenue by Type (2021-2032)
- 12.2.1 SAMEA Membrane Technology in Pharmaceutical Revenue by Type (2021-2026)
- 12.2.2 SAMEA Membrane Technology in Pharmaceutical Revenue by Type (2027-2032)
- 12.3 SAMEA Membrane Technology in Pharmaceutical Revenue Share by Type (2021-2032)
- 12.4 SAMEA Membrane Technology in Pharmaceutical Revenue by Application (2021-2032)
- 12.4.1 SAMEA Membrane Technology in Pharmaceutical Revenue by Application (2021-2026)
- 12.4.2 SAMEA Membrane Technology in Pharmaceutical Revenue by Application (2027-2032)
- 12.5 SAMEA Membrane Technology in Pharmaceutical Revenue Share by Application (2021-2032)
- 12.6 SAMEA Membrane Technology in Pharmaceutical Revenue by Country
- 12.6.1 SAMEA Membrane Technology in Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Membrane Technology in Pharmaceutical Revenue by Country (2021-2026)
- 12.6.3 SAMEA Membrane Technology in Pharmaceutical Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst